HomeRegeneron allays competition fears for ‘gold standard’ eye drug, shares riseFILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid/File Photo

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

August 3, 2023

For investors, green companies still hard to find with new emissions reporting rules

August 3, 2023

Pope, in Portugal to rally young Catholics, says Church needs purification

August 3, 2023

Wall Street ends down, investors step back after Fitch US rating cut

August 2, 2023

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on

Most Read

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

Wall Street ends down, investors step back after Fitch US rating cut

EDITOR PICKS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR POSTS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR CATEGORY